GSK makes strong start to 2025 with growth in sales, profits and earnings
Q1 2025 £m % AER % CER Turnover 7,516 2 4 Total operating profit 2,216 49 50 Total operating margin % 29.5% 9.2ppts 9.0ppts Total EPS 39.7p 55 56 Core…
Q1 2025 £m % AER % CER Turnover 7,516 2 4 Total operating profit 2,216 49 50 Total operating margin % 29.5% 9.2ppts 9.0ppts Total EPS 39.7p 55 56 Core…